{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:16:37Z","timestamp":1783210597002,"version":"3.54.6"},"publisher-location":"Cham","reference-count":87,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032216373","type":"print"},{"value":"9783032216380","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-21638-0_1","type":"book-chapter","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:34:32Z","timestamp":1783208072000},"page":"1-20","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LC-MS-Based Metabolomics and Proteomics Sample Preparation of Urine: Methods and Multi-Omics Integration"],"prefix":"10.1007","author":[{"given":"Muath Khairi","family":"Mousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo M.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"1","key":"1_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41746-019-0185-y","volume":"2","author":"IJ Miller","year":"2019","unstructured":"Miller IJ, Peters SR, Overmyer KA, Paulson BR, Westphall MS, Coon JJ (2019) Real-time health monitoring through urine metabolomics. npj Digit Med 2(1):109. https:\/\/doi.org\/10.1038\/s41746-019-0185-y","journal-title":"npj Digit Med"},{"key":"1_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105008","volume":"101","author":"J Yu","year":"2024","unstructured":"Yu J et al (2024) Using metabolomics and proteomics to identify the potential urine biomarkers for prediction and diagnosis of gestational diabetes. EBioMedicine 101:105008. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105008","journal-title":"EBioMedicine"},{"issue":"5","key":"1_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11427-011-4162-1","volume":"54","author":"C Shao","year":"2011","unstructured":"Shao C, Wang Y, Gao Y (2011) Applications of urinary proteomics in biomarker discovery. Sci China Life Sci 54(5):409\u2013417. https:\/\/doi.org\/10.1007\/s11427-011-4162-1","journal-title":"Sci China Life Sci"},{"issue":"5","key":"1_CR4","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.bbapap.2013.06.016","volume":"1844","author":"E Rodr\u00edguez-Su\u00e1rez","year":"2014","unstructured":"Rodr\u00edguez-Su\u00e1rez E, Siwy J, Z\u00fcrbig P, Mischak H (2014) Urine as a source for clinical proteome analysis: from discovery to clinical application. Biochim Biophys Acta 1844(5):884\u2013898. https:\/\/doi.org\/10.1016\/j.bbapap.2013.06.016","journal-title":"Biochim Biophys Acta"},{"key":"1_CR5","doi-asserted-by":"publisher","unstructured":"Song J et al (2025) Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes. Front Endocrinol 16. https:\/\/doi.org\/10.3389\/fendo.2025.1520436","DOI":"10.3389\/fendo.2025.1520436"},{"issue":"1","key":"1_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/dta.3362","volume":"15","author":"PJ Pascali","year":"2023","unstructured":"Pascali PJ, Giorgetti A, Barone R, Pelletti G, Fais P (2023) Valproic acid determination by liquid chromatography coupled to mass spectrometry (LC\u2013MS\/MS) in whole blood for forensic purposes. Drug Test Anal 15(1):128\u2013133. https:\/\/doi.org\/10.1002\/dta.3362","journal-title":"Drug Test Anal"},{"issue":"1","key":"1_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s43856-023-00238-4","volume":"3","author":"LB Carvalho","year":"2023","unstructured":"Carvalho LB et al (2023) Pathway-guided monitoring of the disease course in bladder cancer with longitudinal urine proteomics. Commun Med 3(1):8","journal-title":"Commun Med"},{"issue":"1","key":"1_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep38885","volume":"6","author":"GD Sitnikov","year":"2016","unstructured":"Sitnikov GD, Monnin SC, Vuckovic D (2016) Systematic assessment of seven solvent and solid-phase extraction methods for metabolomics analysis of human plasma by LC-MS. Sci Rep 6(1):38885. https:\/\/doi.org\/10.1038\/srep38885","journal-title":"Sci Rep"},{"issue":"6","key":"1_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/rcm.8381","volume":"33","author":"W Chan","year":"2019","unstructured":"Chan W, Zhao Y, Zhang J (2019) Evaluating the performance of sample preparation methods for ultra-performance liquid chromatography\/mass spectrometry based serum metabonomics. Rapid Commun Mass Spectrom 33(6):561\u2013568. https:\/\/doi.org\/10.1002\/rcm.8381","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"3","key":"1_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110271","volume":"38","author":"X Bi","year":"2022","unstructured":"Bi X et al (2022) Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19. Cell Rep 38(3):110271. https:\/\/doi.org\/10.1016\/j.celrep.2021.110271","journal-title":"Cell Rep"},{"issue":"1","key":"1_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s11658-023-00452-x","volume":"28","author":"M Lepoittevin","year":"2023","unstructured":"Lepoittevin M, Blancart-Remaury Q, Kerforne T, Pellerin L, Hauet T, Thuillier R (2023) Comparison between 5 extractions methods in either plasma or serum to determine the optimal extraction and matrix combination for human metabolomics. Cell Mol Biol Lett 28(1):43. https:\/\/doi.org\/10.1186\/s11658-023-00452-x","journal-title":"Cell Mol Biol Lett"},{"issue":"7","key":"1_CR12","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.4155\/bio.09.117","volume":"1","author":"C C\u00f4t\u00e9","year":"2009","unstructured":"C\u00f4t\u00e9 C, Bergeron A, Mess J-N, Furtado M, Garofolo F (2009) Matrix effect elimination during LC\u2013MS\/MS bioanalytical method development. Bioanalysis 1(7):1243\u20131257. https:\/\/doi.org\/10.4155\/bio.09.117","journal-title":"Bioanalysis"},{"key":"1_CR13","doi-asserted-by":"publisher","unstructured":"He X, Feng M, Xu X, Zhao H, Qian X (2024) A cartridge structure facilitates clinical mass spectrometry pretreatment and can be integrated into a high-throughput instrument. Sep Sci Plus 7(9). https:\/\/doi.org\/10.1002\/sscp.202400011","DOI":"10.1002\/sscp.202400011"},{"issue":"15","key":"1_CR14","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1002\/jssc.202200255","volume":"45","author":"M Huang","year":"2022","unstructured":"Huang M, Zhou T (2022) Comprehensive pseudotargeted metabolomics analysis based on two-phase liquid extraction-UHPLC-MS\/MS for the investigation of depressive rats. J Sep Sci 45(15):2977\u20132986. https:\/\/doi.org\/10.1002\/jssc.202200255","journal-title":"J Sep Sci"},{"key":"1_CR15","doi-asserted-by":"publisher","unstructured":"Snyder WN, Khezam M, Mesaros AC, Worth A, Blair AI (2013) Untargeted metabolomics from biological sources using ultraperformance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS). J Vis Exp 75. https:\/\/doi.org\/10.3791\/50433","DOI":"10.3791\/50433"},{"issue":"12","key":"1_CR16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s44211-022-00188-2","volume":"38","author":"P Darougheh","year":"2022","unstructured":"Darougheh P, Jazan E, Rezayat RM, Jafari TM (2022) Corona discharge ionization ion mobility spectrometry for ultra-trace determination of methamphetamine extracted from urine and plasma samples by dispersive liquid\u2013liquid microextraction. Anal Sci 38(12):1533\u20131540. https:\/\/doi.org\/10.1007\/s44211-022-00188-2","journal-title":"Anal Sci"},{"issue":"4","key":"1_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7171\/jbt.12-2304-001","volume":"23","author":"A Dutta","year":"2012","unstructured":"Dutta A, Shetty P, Bhat S, Ramachandra Y, Hegde S (2012) A mass spectrometric study for comparative analysis and evaluation of metabolite recovery from plasma by various solvent systems. J Biomol Tech 23(4):128. https:\/\/doi.org\/10.7171\/jbt.12-2304-001","journal-title":"J Biomol Tech"},{"issue":"2","key":"1_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0731-7085(03)00520-X","volume":"34","author":"Y-J Xue","year":"2004","unstructured":"Xue Y-J, Pursley J, Arnold EM (2004) A simple 96-well liquid\u2013liquid extraction with a mixture of acetonitrile and methyl t-butyl ether for the determination of a drug in human plasma by high-performance liquid chromatography with tandem mass spectrometry. J Pharm Biomed Anal 34(2):369\u2013378. https:\/\/doi.org\/10.1016\/S0731-7085(03)00520-X","journal-title":"J Pharm Biomed Anal"},{"issue":"31","key":"1_CR19","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1016\/j.chroma.2009.06.003","volume":"1216","author":"K Deventer","year":"2009","unstructured":"Deventer K, Pozo OJ, Eenoo VP, Delbeke FT (2009) Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography\u2013tandem mass spectrometry. J Chromatogr A 1216(31):5819\u20135827. https:\/\/doi.org\/10.1016\/j.chroma.2009.06.003","journal-title":"J Chromatogr A"},{"issue":"28","key":"1_CR20","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1007\/s00216-014-8124-x","volume":"406","author":"YD Lee","year":"2014","unstructured":"Lee YD, Kind T, Yoon Y-R, Fiehn O, Liu K-H (2014) Comparative evaluation of extraction methods for simultaneous mass-spectrometric analysis of complex lipids and primary metabolites from human blood plasma. Anal Bioanal Chem 406(28):7275\u20137286. https:\/\/doi.org\/10.1007\/s00216-014-8124-x","journal-title":"Anal Bioanal Chem"},{"issue":"8","key":"1_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/chromsci\/47.8.614","volume":"47","author":"L Chen","year":"2009","unstructured":"Chen L et al (2009) On-line coupling of solid-phase extraction to liquid chromatography-a review. J Chromatogr Sci 47(8):614\u2013623. https:\/\/doi.org\/10.1093\/chromsci\/47.8.614","journal-title":"J Chromatogr Sci"},{"issue":"12","key":"1_CR22","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s44211-022-00190-8","volume":"38","author":"IEM Badawy","year":"2022","unstructured":"Badawy IEM, El-Nouby MAM, Kimani KP, Lim WL, Rabea IE (2022) A review of the modern principles and applications of solid-phase extraction techniques in chromatographic analysis. Anal Sci 38(12):1457\u20131487. https:\/\/doi.org\/10.1007\/s44211-022-00190-8","journal-title":"Anal Sci"},{"issue":"4","key":"1_CR23","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.talanta.2007.04.062","volume":"73","author":"N Ferreir\u00f3s","year":"2007","unstructured":"Ferreir\u00f3s N, Iriarte G, Alonso R, Jim\u00e9nez R (2007) Development of a solid phase extraction procedure for HPLC\u2013DAD determination of several angiotensin II receptor antagonists in human urine using mixture design. Talanta 73(4):748\u2013756","journal-title":"Talanta"},{"issue":"4","key":"1_CR24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S1872-2040(21)60091-9","volume":"49","author":"J Jin","year":"2021","unstructured":"Jin J, Song S-J, Peng Z-J, Guo F, Li P-H (2021) Determination of polybrominated diphenyl ethers and hydroxylated analogues in serum using high performance liquid chromatography-inductively coupled plasma mass spectrometry with online solid phase extraction. Chin J Anal Chem 49(4):520\u2013527. https:\/\/doi.org\/10.1016\/S1872-2040(21)60091-9","journal-title":"Chin J Anal Chem"},{"key":"1_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2024.124127","volume":"1239","author":"Y Shen","year":"2024","unstructured":"Shen Y, Luo X, Guan Q, Cheng L (2024) A dilute and shoot method for urinary free cortisol analysis by LC-MS\/MS, (in eng). J Chromatogr B Analyt Technol Biomed Life Sci 1239:124127. https:\/\/doi.org\/10.1016\/j.jchromb.2024.124127","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"7","key":"1_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.tibtech.2014.05.005","volume":"32","author":"JC Roberts","year":"2014","unstructured":"Roberts JC (2014) Therapeutic protein aggregation: mechanisms, design, and control. Trends Biotechnol 32(7):372\u2013380. https:\/\/doi.org\/10.1016\/j.tibtech.2014.05.005","journal-title":"Trends Biotechnol"},{"key":"1_CR27","first-page":"175","volume-title":"Methods in molecular biology","author":"M Court","year":"2015","unstructured":"Court M, Garin J, Masselon DC (2015) Urine sample preparation and fractionation for global proteome profiling by LC-MS. In: Methods in molecular biology, pp 175\u2013186"},{"issue":"1","key":"1_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1021\/pr0502525","volume":"5","author":"V Thongboonkerd","year":"2006","unstructured":"Thongboonkerd V, Chutipongtanate S, Kanlaya R (2006) Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. J Proteome Res 5(1):183\u2013191. https:\/\/doi.org\/10.1021\/pr0502525","journal-title":"J Proteome Res"},{"issue":"2","key":"1_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/mps2020046","volume":"2","author":"S Saito","year":"2019","unstructured":"Saito S et al (2019) The optimized workflow for sample preparation in LC-MS\/MS-based urine proteomics. Methods Protoc 2(2):46. https:\/\/doi.org\/10.3390\/mps2020046","journal-title":"Methods Protoc"},{"issue":"1","key":"1_CR30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1021\/pr900806x","volume":"9","author":"DM Simpson","year":"2010","unstructured":"Simpson DM, Beynon RJ (2010) Acetone precipitation of proteins and the modification of peptides. J Proteome Res 9(1):444\u2013450. https:\/\/doi.org\/10.1021\/pr900806x","journal-title":"J Proteome Res"},{"key":"1_CR31","first-page":"125","volume-title":"Advances in experimental medicine and biology","author":"F S\u00e1nchez-Juanes","year":"2019","unstructured":"S\u00e1nchez-Juanes F, Gonz\u00e1lez-Buitrago MJ (2019) Sample treatment for urine proteomics. In: Advances in experimental medicine and biology, pp 125\u2013135"},{"issue":"4","key":"1_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/jctb.4144","volume":"89","author":"A Fern\u00e1ndez","year":"2014","unstructured":"Fern\u00e1ndez A, Zhu Y, Fitzgerald JR, Riera AF (2014) Membrane fractionation of a \u03b2-lactoglobulin tryptic digest: effect of the membrane characteristics. J Chem Technol Biotechnol 89(4):508\u2013515. https:\/\/doi.org\/10.1002\/jctb.4144","journal-title":"J Chem Technol Biotechnol"},{"issue":"1\u20132","key":"1_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cis.2008.07.004","volume":"145","author":"A Saxena","year":"2009","unstructured":"Saxena A, Tripathi PB, Kumar M, Shahi KV (2009) Membrane-based techniques for the separation and purification of proteins: an overview. Adv Colloid Interf Sci 145(1\u20132):1\u201322. https:\/\/doi.org\/10.1016\/j.cis.2008.07.004","journal-title":"Adv Colloid Interf Sci"},{"issue":"6\u20137","key":"1_CR34","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/jssc.200900554","volume":"33","author":"H Loftheim","year":"2010","unstructured":"Loftheim H, Nguyen DT, Maler\u00f8d H, Lundanes E, \u00c5sberg A, Reubsaet L (2010) 2-D hydrophilic interaction liquid chromatography-RP separation in urinary proteomics\u2014minimizing variability through improved downstream workflow compatibility. J Sep Sci 33(6\u20137):864\u2013872. https:\/\/doi.org\/10.1002\/jssc.200900554","journal-title":"J Sep Sci"},{"issue":"7","key":"1_CR35","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/pmic.200401063","volume":"5","author":"LL Manza","year":"2005","unstructured":"Manza LL, Stamer LS, Ham LA-J, Codreanu GS, Liebler CD (2005) Sample preparation and digestion for proteomic analyses using spin filters. Proteomics 5(7):1742\u20131745. https:\/\/doi.org\/10.1002\/pmic.200401063","journal-title":"Proteomics"},{"issue":"5","key":"1_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"RJ Wi\u015bniewski","year":"2009","unstructured":"Wi\u015bniewski RJ, Zougman A, Nagaraj N, Mann M (2009) Universal sample preparation method for proteome analysis. Nat Methods 6(5):359\u2013362. https:\/\/doi.org\/10.1038\/nmeth.1322","journal-title":"Nat Methods"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.talanta.2017.09.078","volume":"178","author":"RJ Jesus","year":"2018","unstructured":"Jesus RJ, Santos MH, L\u00f3pez-Fern\u00e1ndez H, Lodeiro C, Arruda ZAM, Capelo JL (2018) Ultrasonic-based membrane aided sample preparation of urine proteomes. Talanta 178:864\u2013869. https:\/\/doi.org\/10.1016\/j.talanta.2017.09.078","journal-title":"Talanta"},{"issue":"1","key":"1_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep36120","volume":"6","author":"A Eirin","year":"2016","unstructured":"Eirin A et al (2016) Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem\/stromal cells. Sci Rep 6(1):36120. https:\/\/doi.org\/10.1038\/srep36120","journal-title":"Sci Rep"},{"issue":"5\u20136","key":"1_CR39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/prca.201400085","volume":"9","author":"X Liu","year":"2015","unstructured":"Liu X et al (2015) Intraluminal proteome and peptidome of human urinary extracellular vesicles. Proteomics Clin Appl 9(5\u20136):568\u2013573. https:\/\/doi.org\/10.1002\/prca.201400085","journal-title":"Proteomics Clin Appl"},{"issue":"1","key":"1_CR40","doi-asserted-by":"publisher","first-page":"1313091","DOI":"10.1080\/20013078.2017.1313091","volume":"6","author":"VI Bijnsdorp","year":"2017","unstructured":"Bijnsdorp VI et al (2017) Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method. J Extracell Vesicles 6(1):1313091. https:\/\/doi.org\/10.1080\/20013078.2017.1313091","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"1_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S1872-2040(09)60030-X","volume":"38","author":"Y Dai","year":"2010","unstructured":"Dai Y, Zhang Y, Qiu F, Li Y-Y, Qiu Z-Y (2010) Analysis of differentially expressed proteome in urinary exosome from non-small cell lung cancer patients. Chin J Anal Chem 38(3):325\u2013331. https:\/\/doi.org\/10.1016\/S1872-2040(09)60030-X","journal-title":"Chin J Anal Chem"},{"issue":"11","key":"1_CR42","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1002\/pmic.200401018","volume":"4","author":"J Oh","year":"2004","unstructured":"Oh J et al (2004) Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics 4(11):3485\u20133497. https:\/\/doi.org\/10.1002\/pmic.200401018","journal-title":"Proteomics"},{"issue":"5","key":"1_CR43","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1399-0012.2008.00833.x","volume":"22","author":"KT Sigdel","year":"2008","unstructured":"Sigdel KT, Lau K, Schilling J, Sarwal M (2008) Optimizing protein recovery for urinary proteomics, a tool to monitor renal transplantation. Clin Transpl 22(5):617\u2013623. https:\/\/doi.org\/10.1111\/j.1399-0012.2008.00833.x","journal-title":"Clin Transpl"},{"key":"1_CR44","doi-asserted-by":"publisher","unstructured":"Chen Z, Kim J (2016) Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases. BMC Urol 16(1). https:\/\/doi.org\/10.1186\/s12894-016-0129-7","DOI":"10.1186\/s12894-016-0129-7"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mex.2014.07.002","volume":"1","author":"CS Sapcariu","year":"2014","unstructured":"Sapcariu CS, Kanashova T, Weindl D, Ghelfi J, Dittmar G, Hiller K (2014) Simultaneous extraction of proteins and metabolites from cells in culture. MethodsX 1:74\u201380. https:\/\/doi.org\/10.1016\/j.mex.2014.07.002","journal-title":"MethodsX"},{"key":"1_CR46","doi-asserted-by":"publisher","unstructured":"Gegner MH et al (2024) A single-sample workflow for joint metabolomic and proteomic analysis of clinical specimens. Clin Proteomics 21(1). https:\/\/doi.org\/10.1186\/s12014-024-09501-9","DOI":"10.1186\/s12014-024-09501-9"},{"issue":"3","key":"1_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mSystems.00043-16","volume":"1","author":"ES Nakayasu","year":"2016","unstructured":"Nakayasu ES et al (2016) MPLEx: a robust and universal protocol for single-sample integrative proteomic, metabolomic, and lipidomic analyses. MSystems 1(3):10\u20131128","journal-title":"MSystems"},{"key":"1_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2022.123806","volume":"253","author":"J Faugere","year":"2023","unstructured":"Faugere J et al (2023) Development of a multi-omics extraction method for ecotoxicology: investigation of the reproductive cycle of Gammarus fossarum. Talanta 253:123806. https:\/\/doi.org\/10.1016\/j.talanta.2022.123806","journal-title":"Talanta"},{"issue":"8","key":"1_CR49","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KK, Kiemeney LA (2020) The global burden of urinary bladder cancer: an update. World J Urol 38(8):1895\u20131904","journal-title":"World J Urol"},{"issue":"5","key":"1_CR50","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LM van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LM, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA (2023) Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol 20(5):287\u2013304","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"1_CR51","doi-asserted-by":"publisher","first-page":"692","DOI":"10.21037\/tau.2016.06.13","volume":"5","author":"Y Klaile","year":"2016","unstructured":"Klaile Y, Schlack K, Boegemann M, Steinestel J, Schrader JA, Krabbe L-M (2016) Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? Transl Androl Urol 5(5):692\u2013701. https:\/\/doi.org\/10.21037\/tau.2016.06.13","journal-title":"Transl Androl Urol"},{"issue":"4","key":"1_CR52","doi-asserted-by":"publisher","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","volume":"22","author":"TW Flaig","year":"2024","unstructured":"Flaig TW et al (2024) Bladder cancer, version 3.2024 featured updates to the NCCN guidelines. JNCCN J Natl Compr Cancer Netw 22(4):216\u2013225","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"issue":"1","key":"1_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5584\/jiomics.v15i1.245","volume":"15","author":"ARMJ Montes","year":"2025","unstructured":"Montes ARMJ et al (2025) Differential urinary proteomics and absolute protein quantification reveal biomarkers of muscle-invasive and non-muscle-invasive bladder cancer. J Integr OMICS 15(1):5\u201311. https:\/\/doi.org\/10.5584\/jiomics.v15i1.245","journal-title":"J Integr OMICS"},{"issue":"4","key":"1_CR54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ajur.2023.04.007","volume":"11","author":"N Ahmadi","year":"2024","unstructured":"Ahmadi N, Shafee H, Moudi E (2024) Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer. Asian J Urol 11(4):625\u2013632. https:\/\/doi.org\/10.1016\/j.ajur.2023.04.007","journal-title":"Asian J Urol"},{"issue":"17","key":"1_CR55","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.7150\/jca.28989","volume":"10","author":"C-Z Zhu","year":"2019","unstructured":"Zhu C-Z, Ting H-N, Ng K-H, Ong T-A (2019) A review on the accuracy of bladder cancer detection methods. J Cancer 10(17):4038\u20134044. https:\/\/doi.org\/10.7150\/jca.28989","journal-title":"J Cancer"},{"issue":"17","key":"1_CR56","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1002\/cncr.28147","volume":"119","author":"K Chamie","year":"2013","unstructured":"Chamie K et al (2013) Recurrence of high-risk bladder cancer: a population-based analysis. Cancer 119(17):3219\u20133227. https:\/\/doi.org\/10.1002\/cncr.28147","journal-title":"Cancer"},{"key":"1_CR57","unstructured":"B. C. A. Network (2025) Bladder cancer types, stages & grades. (accessed 19 Nov 2025)"},{"key":"1_CR58","doi-asserted-by":"publisher","unstructured":"Fang W, Yang Z-Y, Chen T-Y, Shen X-F, Zhang C (2020) Ethnicity and survival in bladder cancer: a population-based study based on the SEER database. J Transl Med 18(1). https:\/\/doi.org\/10.1186\/s12967-020-02308-w","DOI":"10.1186\/s12967-020-02308-w"},{"issue":"1","key":"1_CR59","doi-asserted-by":"publisher","first-page":"272","DOI":"10.30574\/wjbphs.2023.13.1.0017","volume":"13","author":"NP Jyothi","year":"2023","unstructured":"Jyothi NP, Sreemahalaksmi G, Prathyusha SG, Swapna M (2023) Carcinoma of bladder: a rare case report. World J Biol Pharm Health Sci 13(1):272\u2013276. https:\/\/doi.org\/10.30574\/wjbphs.2023.13.1.0017","journal-title":"World J Biol Pharm Health Sci"},{"key":"1_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103577","volume":"170","author":"F Crocetto","year":"2022","unstructured":"Crocetto F et al (2022) Liquid biopsy in bladder cancer: state of the art and future perspectives. Crit Rev Oncol Hematol 170:103577","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"1_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010160","volume":"16","author":"CS Guldhammer","year":"2023","unstructured":"Guldhammer CS et al (2023) Cystoscopy accuracy in detecting bladder tumors: a prospective video-confirmed study. Cancer 16(1):160","journal-title":"Cancer"},{"issue":"2","key":"1_CR62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ucl.2015.01.001","volume":"42","author":"DV Zlatev","year":"2015","unstructured":"Zlatev DV, Altobelli E, Liao JC (2015) Advances in imaging technologies in the evaluation of high-grade bladder cancer. Urol Clin North Am 42(2):147","journal-title":"Urol Clin North Am"},{"key":"1_CR63","volume-title":"Urologic oncology: seminars and original investigations","author":"F Chen","year":"2025","unstructured":"Chen F, Simsir A, Cheng L (2025) Molecular testing in urinary cytology specimens: current status and future directions. In: Urologic oncology: seminars and original investigations. Elsevier"},{"issue":"6","key":"1_CR64","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.juro.2008.01.084","volume":"179","author":"HJ Issaq","year":"2008","unstructured":"Issaq HJ et al (2008) Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography\/mass spectrometry. J Urol 179(6):2422\u20132426","journal-title":"J Urol"},{"issue":"6","key":"1_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063347","volume":"25","author":"F Pereira","year":"2024","unstructured":"Pereira F et al (2024) Unmasking the metabolite signature of bladder cancer: a systematic review. Int J Mol Sci 25(6):3347. https:\/\/doi.org\/10.3390\/ijms25063347","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ajur.2022.11.005","volume":"11","author":"AH Garc\u00eda-Perdomo","year":"2024","unstructured":"Garc\u00eda-Perdomo AH, D\u00e1vila-Raigoza MA, Korkes F (2024) Metabolomics for the diagnosis of bladder cancer: a systematic review. Asian J Urol 11(2):221\u2013241. https:\/\/doi.org\/10.1016\/j.ajur.2022.11.005","journal-title":"Asian J Urol"},{"issue":"1","key":"1_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/omi.2014.0116","volume":"19","author":"C Shen","year":"2015","unstructured":"Shen C et al (2015) Developing urinary metabolomic signatures as early bladder cancer diagnostic markers. OMICS 19(1):1\u201311. https:\/\/doi.org\/10.1089\/omi.2014.0116","journal-title":"OMICS"},{"issue":"1","key":"1_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11255-021-03080-6","volume":"54","author":"J Li","year":"2022","unstructured":"Li J, Cheng B, Xie H, Zhan C, Li S, Bai P (2022) Bladder cancer biomarker screening based on non-targeted urine metabolomics. Int Urol Nephrol 54(1):23\u201329. https:\/\/link.springer.com\/article\/10.1007\/s11255-021-03080-6","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"1_CR69","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.18632\/oncotarget.1744","volume":"5","author":"X Jin","year":"2014","unstructured":"Jin X, Yun JS, Jeong P, Kim YI, Kim W-J, Park S (2014) Diagnosis of bladder cancer and prediction of survival by urinary metabolomics. Oncotarget 5(6):1635\u20131645. https:\/\/doi.org\/10.18632\/oncotarget.1744","journal-title":"Oncotarget"},{"key":"1_CR70","doi-asserted-by":"publisher","unstructured":"Nizio\u0142 J et al (2023) Untargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry. Sci Rep 13(1). https:\/\/doi.org\/10.1038\/s41598-023-36874-y","DOI":"10.1038\/s41598-023-36874-y"},{"issue":"12","key":"1_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115870","volume":"9","author":"MB Wittmann","year":"2014","unstructured":"Wittmann MB et al (2014) Bladder cancer biomarker discovery using global metabolomic profiling of urine. PLoS One 9(12):e115870. https:\/\/doi.org\/10.1371\/journal.pone.0115870","journal-title":"PLoS One"},{"issue":"2","key":"1_CR72","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/ijc.31323","volume":"143","author":"X Liu","year":"2018","unstructured":"Liu X et al (2018) Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery. Int J Cancer 143(2):408\u2013418. https:\/\/doi.org\/10.1002\/ijc.31323","journal-title":"Int J Cancer"},{"key":"1_CR73","doi-asserted-by":"publisher","unstructured":"Zhou X et al (2024) Exploration of potential biomarkers for early bladder cancer based on urine proteomics. Front Oncol 14. https:\/\/doi.org\/10.3389\/fonc.2024.1309842","DOI":"10.3389\/fonc.2024.1309842"},{"issue":"56","key":"1_CR74","doi-asserted-by":"publisher","first-page":"30731","DOI":"10.18632\/oncotarget.24578","volume":"9","author":"C-H Tsai","year":"2018","unstructured":"Tsai C-H et al (2018) Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens. Oncotarget 9(56):30731\u201330747. https:\/\/doi.org\/10.18632\/oncotarget.24578","journal-title":"Oncotarget"},{"issue":"7","key":"1_CR75","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1021\/acs.jproteome.6b00106","volume":"15","author":"J Guo","year":"2016","unstructured":"Guo J et al (2016) A comprehensive investigation toward the indicative proteins of bladder cancer in urine: from surveying cell secretomes to verifying urine proteins. J Proteome Res 15(7):2164\u20132177. https:\/\/doi.org\/10.1021\/acs.jproteome.6b00106","journal-title":"J Proteome Res"},{"issue":"15","key":"1_CR76","doi-asserted-by":"publisher","first-page":"13539","DOI":"10.18632\/oncotarget.3841","volume":"6","author":"P Kumar","year":"2015","unstructured":"Kumar P et al (2015) Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma. Oncotarget 6(15):13539\u201313549. https:\/\/doi.org\/10.18632\/oncotarget.3841","journal-title":"Oncotarget"},{"issue":"1","key":"1_CR77","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00345-009-0432-y","volume":"28","author":"L-B Tan","year":"2010","unstructured":"Tan L-B, Chen K-T, Yuan Y-C, Liao P-C, Guo H-R (2010) Identification of urine PLK2 as a marker of bladder tumors by proteomic analysis. World J Urol 28(1):117\u2013122. https:\/\/doi.org\/10.1007\/s00345-009-0432-y","journal-title":"World J Urol"},{"issue":"10","key":"1_CR78","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-10-3121","volume":"17","author":"N Yang","year":"2011","unstructured":"Yang N et al (2011) Urinary glycoprotein biomarker discovery for bladder cancer detection using LC\/MS-MS and label-free quantification. Clin Cancer Res 17(10):3349\u20133359. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-3121","journal-title":"Clin Cancer Res"},{"key":"1_CR79","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jprot.2013.04.024","volume":"85","author":"C-L Chen","year":"2013","unstructured":"Chen C-L et al (2013) Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics. J Proteome 85:28\u201343. https:\/\/doi.org\/10.1016\/j.jprot.2013.04.024","journal-title":"J Proteome"},{"issue":"8","key":"1_CR80","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.21037\/tau-21-562","volume":"10","author":"X Li","year":"2021","unstructured":"Li X et al (2021) Discovery of bladder cancer biomarkers in paired pre- and postoperative urine samples. Transl Androl Urol 10(8):3402\u20133414. https:\/\/doi.org\/10.21037\/tau-21-562","journal-title":"Transl Androl Urol"},{"issue":"3","key":"1_CR81","doi-asserted-by":"publisher","first-page":"882","DOI":"10.4143\/crt.2021.642","volume":"54","author":"J Suh","year":"2022","unstructured":"Suh J, Han D, Ku HJ, Kim HH, Kwak C, Jeong WC (2022) Next-generation proteomics-based discovery, verification, and validation of urine biomarkers for bladder cancer diagnosis. Cancer Res Treat 54(3):882\u2013893. https:\/\/doi.org\/10.4143\/crt.2021.642","journal-title":"Cancer Res Treat"},{"issue":"6","key":"1_CR82","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1021\/acs.jproteome.4c00199","volume":"23","author":"Q Chang","year":"2024","unstructured":"Chang Q et al (2024) Comprehensive urinary proteome profiling analysis identifies diagnosis and relapse surveillance biomarkers for bladder cancer. J Proteome Res 23(6):2241\u20132252. https:\/\/doi.org\/10.1021\/acs.jproteome.4c00199","journal-title":"J Proteome Res"},{"issue":"6_Supplement","key":"1_CR83","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1158\/1538-7445.AM2024-3762","volume":"84","author":"C Mohan","year":"2024","unstructured":"Mohan C, Vanarsa K, Castillo J, Wang L, Lotan Y (2024) Abstract 3762: 11,000-plex aptamer based proteomics of bladder cancer urine for the discovery of novel disease biomarkers. Cancer Res 84(6_Supplement):3762\u20133762. https:\/\/doi.org\/10.1158\/1538-7445.AM2024-3762","journal-title":"Cancer Res"},{"issue":"1","key":"1_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/1477-5956-9-21","volume":"9","author":"H Li","year":"2011","unstructured":"Li H et al (2011) Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma. Proteome Sci 9(1):21. https:\/\/doi.org\/10.1186\/1477-5956-9-21","journal-title":"Proteome Sci"},{"key":"1_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.120022","volume":"565","author":"X Shi","year":"2025","unstructured":"Shi X et al (2025) UPLC-Q-TOF\/MS-based urine metabolomics for the diagnosis and staging of bladder cancer. Clin Chim Acta 565:120022. https:\/\/doi.org\/10.1016\/j.cca.2024.120022","journal-title":"Clin Chim Acta"},{"issue":"S1","key":"1_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.01764","volume":"34","author":"X Tang","year":"2020","unstructured":"Tang X et al (2020) Urine metabolomics and proteomics for bladder cancer prediction by LC\/MS based strategy. FASEB J 34(S1):1\u20131. https:\/\/doi.org\/10.1096\/fasebj.2020.34.s1.01764","journal-title":"FASEB J"},{"key":"1_CR87","doi-asserted-by":"publisher","unstructured":"Woodland B et al (2025) Sample preparation for multi-omics analysis: considerations and guidance for identifying the ideal workflow. Proteomics. https:\/\/doi.org\/10.1002\/pmic.13983","DOI":"10.1002\/pmic.13983"}],"container-title":["Advances in Experimental Medicine and Biology","Emerging Sample Treatments in Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-21638-0_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:34:35Z","timestamp":1783208075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-21638-0_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032216373","9783032216380"],"references-count":87,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-21638-0_1","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 June 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}